Vertex raises 2026 revenue guidance, reports Crinetics deal close and povetacicept PDUFA dateNov 2Quarterly updatepovetaciceptVertex Pharmaceuticals Inc / Ma
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Sign inSign in